Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Bath & Body Works, Inc. (BBWI) SEC Filings & Earnings Calls

EquiReason read 13 Bath & Body Works, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-23 — Bath & Body Works granted CEO Daniel Heaf a performance stock unit award with target value of $10M tied to stock price goals over four years..

Source: SEC EDGAR filings · figures as of 2026-08-01 · read by EquiReason

BBWIBath & Body Works, Inc.Follow BBWI — free
Specialty Retail · Consumer Cyclical
—
Price chart with a free account
Market cap
4.2B
P/E TTM
5.5
Dividend yield
3.8%
52-week
—
Next earnings
18 Nov, in 25 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

23 Sep 20268-K · 5.02Bath & Body Works granted CEO Daniel Heaf a performance stock unit award with target value of $10M tied to stock price goals over four years.open

Risks flagged

Compensation tied to stock price performance may incentivize short-term actions; relative TSR modifier adds complexity.

“The number of PSUs otherwise earned will be reduced by 50% if the Company’s total shareholder return relative to the S&P 1500 Consumer Discretionary Distribution & Retail Index is below the 55th percentile.”
Read the original on SEC EDGAR ↗
26 Aug 202610-QQ2 2026 net sales -2.3% YoY, operating income +37% YoY, gross margin +440 bps driven by ~$80M IEEPA tariff refunds.earningsopen

Figures in the filing · each found in the filing text

Net Sales · Q2-2026$1.51B-2% y/y
Gross Profit · Q2-2026$692M+8% y/y
Operating Income · Q2-2026$216M+38% y/y
Net Income · Q2-2026$118M+84% y/y
EPS Diluted · Q2-2026$0.58+93% y/y
Adjusted Operating Income · Q2-2026$225M+31% y/y
Adjusted EPS Diluted · Q2-2026$0.62+68% y/y
Sales per Average Selling Square Foot · Stores - U.S. and Canada · Q2-2026$206.00-7% y/y
Sales per Average Store · Stores - U.S. and Canada · Q2-2026$586000.00-7% y/y
Store Count · Company-operated · Q2-20261,937

Risks flagged

Store sales decline

“Stores Net Sales decreased $65 million, or 5.4%, driven by a decrease in transactions and average dollar sales.” · word for word

Non-recurring margin benefit

“approximately $80 million of IEEPA tariff refunds” · word for word

Marketing spend increase

“Marketing Expenses increased driven by incremental spend and strategic investments to support the Consumer First Formula”
Read the original on SEC EDGAR ↗
26 Aug 20268-K · 2.02, 7.01Q2 net sales $1.514B (down 2.3% YoY) and adj. EPS $0.62 exceeded guidance; full-year EPS guidance raised to $3.13-3.33 from $3.11; net sales guidance narrowed to decline 4%-2.5%; transformation progress noted.earningsopen

Figures in the filing · each found in the filing text

Net sales · Q2-2026$1.51B-2% y/y
Earnings per diluted share · Q2-2026$0.58+93% y/y
Adjusted earnings per diluted share · Q2-2026$0.62+68% y/y
Operating income · Q2-2026$216M+38% y/y
Net income · Q2-2026$118M+84% y/y
Free cash flow · FY2026$650M

Guidance

FY26 EPS raised to $3.13-3.33 from $3.11; adj. EPS raised to $2.60-2.80 from $3.21; net sales guidance narrowed to decline 4%-2.5% from prior range; Q3 EPS $0.05-0.10; Q3 adj. EPS $0.07-0.12; FY26 free cash flow ~$650M.

Full-year EPS guidance raised despite sales decline; Q3 guidance weak; management optimistic on transformation progress.

Risks flagged

Underlying business trends remain pressured despite Q2 beat; transformation still early.

“Underlying business trends remain pressured, but we are seeing further evidence that elements of the Consumer First Formula are beginning to work.” · word for word

Tariff refunds are non-recurring; excluding them adj. EPS would have been $0.31 vs reported $0.62.

“Excluding the refund benefit, second quarter 2026 adjusted earnings per diluted share would have been $0.31.” · word for word

No share repurchases assumed in outlook; limits capital return support.

“There are no share repurchases assumed in our outlook.” · word for word
Read the original on SEC EDGAR ↗
20 Jul 20268-K · 7.01Bath & Body Works issued a notice of partial redemption for $250M of its 7.500% Senior Notes due 2029, with a redemption date of August 19, 2026, at 101.250% of principal plus accrued interest.open

Risks flagged

Debt redemption reduces cash reserves but lowers future interest obligations.

“Redemption price 101.250% of principal plus accrued interest.”
Read the original on SEC EDGAR ↗
27 May 20268-K · 2.02, 5.02, 7.01Net Sales $1.38B (-3% y/y); Earnings per diluted share $0.90 (+84% y/y); Adjusted earnings per diluted share $0.32; Guidance: Full-year 2026 net sales decline 4.5% to 2.5%; EPS $3.00-$3.25; adjusted EPS $2.40-$2.65earningsopen

Figures in the filing · each found in the filing text

Net Sales · Q1-2026$1.38B-3% y/y
Earnings per diluted share · Q1-2026$0.90+84% y/y
Adjusted earnings per diluted share · Q1-2026$0.32
Operating income · Q1-2026$231M+11% y/y
Net income · Q1-2026$183M+74% y/y
Free cash flow · FY2026$600M

Guidance

Full-year 2026 net sales decline 4.5% to 2.5%; EPS $3.00-$3.25; adjusted EPS $2.40-$2.65

Full-year guidance reaffirmed despite Q1 beat; sales decline expected to continue

Risks flagged

CFO departure creates execution risk during transformation

“CFO Eva Boratto to step down June 12; interim CFO appointed with active search”

Sales decline persists despite beat

“Q1 net sales down 3% YoY; full-year guidance implies further decline of 2.5%-4.5%”
Read the original on SEC EDGAR ↗
27 May 202610-QNet Sales $1.38B (-3% y/y); Gross Profit $587M (-9% y/y); Operating Income $231M (+10% y/y); Guidance: FY2026 capex guided ~$270Mopen

Figures in the filing · each found in the filing text

Net Sales · Q1-2026$1.38B-3% y/y
Gross Profit · Q1-2026$587M-9% y/y
Operating Income · Q1-2026$231M+10% y/y
Net Income · Q1-2026$183M+74% y/y
Net Income per Diluted Share · Q1-2026$0.90+84% y/y
Gross Profit Rate · Q1-202642.6%
Capital Expenditures · Q1-2026$49M+32% y/y
Cash and Cash Equivalents · Q1-2026$820M+29% y/y
Inventories · Q1-2026$782M-10% y/y
Sales per Average Selling Square Foot · Stores - U.S. and Canada · Q1-2026$194.00-6% y/y

Guidance

FY2026 capex guided ~$270M

No explicit revenue or EPS guidance provided. Capex guided at ~$270M for FY2026. Management expresses optimism about Consumer First Formula but acknowledges near-term headwinds.

Risks flagged

Geopolitical risk from Middle East conflict

“the conflict between U.S. and Iran escalated and expanded to include much of the Middle East region. This has led to transportation restrictions in the region, resulting in volatility in global energy markets, commodities pricing, transportation costs and foreign currency exchange rates.” · word for word

Tariff refund uncertainty

“As of May 2, 2026, we had not recognized the effect of any potential refunds as the timing and amount of any potential refunds for previously collected tariffs was uncertain.” · word for word

Gross margin pressure from input costs

“Gross Profit rate decreased primarily due to the lower merchandise margin rate, primarily driven by tariffs, inflation and crude oil impacts as well as category mix.” · word for word
Read the original on SEC EDGAR ↗
28 Apr 2026DEF 14ANet Sales $7.30B (-0% y/y); Operating Income Margin (GAAP) 15.4; Adjusted Operating Income Margin 15.9open

Figures in the filing · each found in the filing text

Net Sales · FY2025$7.30B-0% y/y
Operating Income Margin (GAAP) · FY202515.4%
Adjusted Operating Income Margin · FY202515.9%
Net Income Per Diluted Share (GAAP) · FY2025$3.11
Adjusted Net Income Per Diluted Share · FY2025$3.21
Free Cash Flow · FY2025$865M
Dividends Paid · FY2025$167M
Share Repurchases · FY2025$400M
Cost Savings Target · FY2026-FY2027$250M
Loyalty Program Members · FY202540,000,000

Risks flagged

Consumer demand sensitivity

“In 2025, performance was impacted significantly by consumer sentiment as consumers remained cautious and value seeking throughout the year, and by tariffs (which we did not adjust performance targets for).” · word for word

Strategic transformation execution risk

“Our ability to successfully execute this transformation is subject to various risks and uncertainties, such as our ability to successfully execute our plan, changes in consumer demands and trends, general economic conditions, and other risks.”

Tariff input cost pressure

“In 2025, performance was impacted significantly by consumer sentiment as consumers remained cautious and value seeking throughout the year, and by tariffs (which we did not adjust performance targets for).” · word for word
Read the original on SEC EDGAR ↗
12 Mar 202610-KNet Sales $7.30B (-0% y/y); Operating Income (GAAP) $1.13B; Operating Income Margin (GAAP) 15.4open

Figures in the filing · each found in the filing text

Net Sales · FY2025$7.30B-0% y/y
Operating Income (GAAP) · FY2025$1.13B
Operating Income Margin (GAAP) · FY202515.4%
Adjusted Operating Income · FY2025$1.16B
Adjusted Operating Income Margin · FY202515.9%
Net Income (GAAP) · FY2025$649M
Net Income Per Diluted Share (GAAP) · FY2025$3.11
Adjusted Net Income Per Diluted Share · FY2025$3.21
Free Cash Flow · FY2025$865M
Capital Expenditures · FY2025$237M

Risks flagged

Consumer demand sensitivity

“In 2025, performance was impacted significantly by consumer sentiment as consumers remained cautious and value seeking throughout the year, and by tariffs (which we did not adjust performance targets for).”

Tariff input cost pressure

“In 2025, performance was impacted significantly by consumer sentiment as consumers remained cautious and value seeking throughout the year, and by tariffs (which we did not adjust performance targets for).”

Strategic transformation execution risk

“Our ability to successfully execute this transformation is subject to various risks and uncertainties, such as our ability to successfully execute our plan, changes in consumer demands and trends, general economic conditions, and other risks.” · word for word

Seasonal concentration risk

“Our operations are seasonal in nature and the fourth quarter, including the holiday selling season, typically accounts for approximately 40% of our Net Sales and is our most profitable quarter.” · word for word
Read the original on SEC EDGAR ↗
4 Mar 20268-K · 2.02, 7.01Net sales $2.72B (-2% y/y); Earnings per diluted share $1.99 (-5% y/y); Adjusted earnings per diluted share $2.05; Guidance: FY2026 net sales down 4.5% to 2.5%; EPS $3.00-$3.25; adjusted EPS $2.40-$2.65earningsopen

Figures in the filing · each found in the filing text

Net sales · Q4-2025$2.72B-2% y/y
Earnings per diluted share · Q4-2025$1.99-5% y/y
Adjusted earnings per diluted share · Q4-2025$2.05
Operating income · Q4-2025$599M-12% y/y
Net income · Q4-2025$403M-11% y/y
Adjusted operating income · Q4-2025$614M
Adjusted net income · Q4-2025$415M

Guidance

FY2026 net sales down 4.5% to 2.5%; EPS $3.00-$3.25; adjusted EPS $2.40-$2.65

FY2026 guidance implies further sales decline; transformation costs and brand repositioning.

Risks flagged

Transformation costs and sales decline; guidance implies further revenue contraction.

“pre-tax costs of $15 million ($12 million after tax) associated with business transformation activities” · word for word
Read the original on SEC EDGAR ↗
3 Mar 20268-K · 7.01Bath & Body Works issued a notice of redemption for all outstanding 6.694% Senior Notes due 2027, with redemption date April 10, 2026. This is a debt refinancing event, not a new issuance or default.open

Risks flagged

No new risk signals; redemption is a routine capital management action.

Read the original on SEC EDGAR ↗
25 Feb 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen

Risks flagged

Key legal officer departure may create temporary leadership gap; search for successor underway.

“The Company has initiated a search to identify the Company’s next Chief Legal Officer.” · word for word
Read the original on SEC EDGAR ↗
20 Nov 202510-QBath & Body Works reported Q3 2025 results below expectations with a 1% sales decline and 26.1% operating income drop, and management noted continued weakness into Q4.earningsopen

Figures in the filing · each found in the filing text

Net Sales · Q3-2025$1.59B-1% y/y
Operating Income · Q3-2025$161M-26% y/y
Net Income · Q3-2025$77M-27% y/y
Net Income per Diluted Share · Q3-2025$0.37-25% y/y
Adjusted Net Income Per Diluted Share · Q3-2025$0.35-29% y/y
Gross Profit · Q3-2025$658M-6% y/y
Operating Cash Flow · YTD-2025$225M
Capital Expenditures · YTD-2025$174M+5% y/y
Sales per Average Selling Square Foot · Stores - U.S. and Canada · Q3-2025$222.00-2% y/y
Sales per Average Store · Stores - U.S. and Canada · Q3-2025$630000.00-2% y/y

Guidance

Q3 results below expectations; trends continued into Q4

Management states Q3 results were below expectations and negative trends have continued into Q4, indicating a de facto guidance cut.

Risks flagged

Consumer demand weakness

“We believe that macro consumer sentiment is weighing on our consumers’ purchase intent and that the holiday season is shaping up to be highly competitive.” · word for word

Margin compression

“Our third quarter Operating Income was $161 million, which decreased $57 million, or 26.1%, compared to the third quarter of 2024, and our Operating Income rate decreased to 10.1% from 13.5%.” · word for word

Competitive pressure

“the holiday season is shaping up to be highly competitive.” · word for word

Transformation execution risk

“We are announcing a holistic growth plan to revitalize the business across brand, product and marketplace.” · word for word
Read the original on SEC EDGAR ↗
20 Nov 20258-K · 2.02, 7.01Net sales $1.59B (-1% y/y); earnings per diluted share $0.37 (-24% y/y); adjusted earnings per diluted share $0.35; Guidance: FY2025 net sales guidance from 1.5%-2.7% growth to decline of low single digits; FY2025 EPS at least $2.83 vs $3.6earningsopen

Figures in the filing · each found in the filing text

net sales · Q3-2025$1.59B-1% y/y
earnings per diluted share · Q3-2025$0.37-25% y/y
adjusted earnings per diluted share · Q3-2025$0.35
operating income · Q3-2025$161M-26% y/y
net income · Q3-2025$77M-27% y/y
free cash flow · FY2025$650M

Guidance

FY2025 net sales guidance from 1.5%-2.7% growth to decline of low single digits; FY2025 EPS at least $2.83 vs $3.61 prior year

Guidance cut due to macro consumer pressures and tariff impacts.

Risks flagged

Macro consumer pressures and tariff impacts weighing on demand and margins.

“Q4 and full-year 2025 guidance lowered reflecting current business trends and continuation of recent macro consumer pressures.” · word for word
Read the original on SEC EDGAR ↗

Bath & Body Works, Inc. — questions

What did Bath & Body Works, Inc. file recently?
13 SEC filings in the last 12 months. Latest: 8-K on 2026-09-23 — Bath & Body Works granted CEO Daniel Heaf a performance stock unit award with target value of $10M tied to stock price goals over four years.

Every figure on this page comes from Bath & Body Works, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.